Sunzen Biotech Bhd (XKLS:0148) LT-Debt-to-Total-Asset : 0.04 (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Sunzen Biotech Bhd LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sunzen Biotech Bhd's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.04.

Sunzen Biotech Bhd's long-term debt to total assets ratio increased from Mar. 2023 (0.03) to Jun. 2024 (0.04). It may suggest that Sunzen Biotech Bhd is progressively becoming more dependent on debt to grow their business.

Sunzen Biotech Bhd LT-Debt-to-Total-Asset Historical Data

The historical data trend for Sunzen Biotech Bhd's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunzen Biotech Bhd LT-Debt-to-Total-Asset Chart

Sunzen Biotech Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Jun24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.12

0.04

0.03

0.04

Sunzen Biotech Bhd Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.04	0.04

Sunzen Biotech Bhd LT-Debt-to-Total-Asset Calculation

Sunzen Biotech Bhd's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )	/	Total Assets (A: Jun. 2024 )
	=	7.001	/	170.352
	=

Sunzen Biotech Bhd's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	7.001	/	170.352
	=	0.04

Sunzen Biotech Bhd (XKLS:0148) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Sunzen Biotech Bhd LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Sunzen Biotech Bhd's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunzen Biotech Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sunzen Biotech Bhd (XKLS:0148) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, Jalan Anggerik Mokara 31/47, Kota Kemuning, Shah Alam, SGR, MYS, 40460

Website

https://www.sunzen.com.my

Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing; and Loan Financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment. Geographically, it operates into Malaysia, China, Singapore, and Others, out of which Malaysia generates maximum revenue.

Sunzen Biotech Bhd Headlines

No Headlines